- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Mar 14, 2016
Emerging Company Profile
AMO's CNS ammunition
AMO is repurposing compounds to treat CNS deficits in fragile X and DM1
Items per page:
1 - 2 of 2